Zejula (niraparib) capsules - GSKpro
17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. 2 _____ FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . 1.1 First-Line Maintenance Treatment of Advanced Ovarian Cancer . ZEJULA is indicated for the maintenance treatment of adult patients with advanced epithelial ...
Tags:
Information, Patients, Niraparib
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
NUCALA (mepolizumab) for injection NUCALA (mepolizumab ...
gskpro.com17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. _____ 2 . FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . 1.1 Maintenance Treatment of Severe Asthma . NUCALA is indicated for the add-on maintenance treatment of adult and pediatric patients aged ...
LAMICTAL (lamotrigine) Tablets LAMICTAL (lamotrigine ...
gskpro.comcould cause serious arrhythmias and/or death in patients with certain underlying cardiac disorders or arrhythmias. Any expected or observed benefit of LAMICTAL in an individual patient with clinically important structural or functional heart disease must be carefully weighed against the risk for serious arrythmias and/or death for that patient .
JEMPERLI (dostarlimab-gxly) injection
gskpro.com• Complications of allogeneic hematopoietic stem cell transplantation (HSCT): Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1–blocking antibody. (5.3) • Embryo-fetal toxicity: Can cause fetal harm. Advise females of
BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and ...
gskpro.com• The tip caps of the prefilled syringes contain natural rubber latex which may cause allergic reactions. (5.2) ... whenever solution and container permit. Do not use the vaccine if either ... BOOSTRIX is a suspension for injection available in 0.5-mL single-dose vials and prefilled
ZENTEL® Albendazol 200 mg Tabletas
gskpro.comZENTEL® está contraindicado durante el embarazo, y durante un mes antes de la concepción. Con el fin de evitar la administración de albendazol durante el embarazo precoz, las mujeres en edad fértil deben iniciar el tratamiento durante la primera semana de la menstruación o después de una prueba de embarazo negativa. 4 . RD N°22158-2015 2da.
ZYRTEC ORAL DROPS 10 mg/ml ZYRTEC ORAL SOLUTION 1 …
gskpro.comCetirizine dihydrochloride, a metabolite of hydroxyzine, is an anti-allergic agent, with a histamine H 1 receptor antagonism devoid of any significant anticholinergic and antiserotonin effects as demonstrated in experimental and clinical pharmacology.
ゼビュディ点滴静注 調製・投与方法のご案内
gskpro.com5）Fadini GP, et al. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 2020. 6）Zheng Z, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
GSKPro for Healthcare Professionals
gskpro.comPriming VENTOLIN HFA is essential to ensure appropriate albuterol content in each actuation. Prime VENTOLIN HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped. To prime VENTOLIN HFA, release 4 sprays into the air away f rom the face, shaking well before each spray.
Guía para el uso racional de antibióticos
gskpro.comO’Neil J.Tackling drug-resistant infections globally: fi nal report and recommendations. Chaired by Jim O` Neil.[Internet] Mayo 2016. [Último acceso: junio 2018].
INFECCIONES DEL TRACTO URINARIO (ITU)
gskpro.comStaphylococcus saprophyticus en mujeres jóvenes sanas. 6 Resistencia antimicrobiana. Definición y epidemiología Etiología Manifestaciones clínicas Diagnóstico Tratamiento INFECCIONES DEL TRACTO URINARIO (ITU) MANIFESTACIONES CLÍNICAS Cistitis aguda simple en mujeres
Related documents
CALQUENCE PRESCRIBING INFORMATION
www.azpicentral.comSee 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 11/2019 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Mantle Cell Lymphoma 1.2 Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 …
TAGRISSO PRESCRIBING INFORMATION
www.azpicentral.com17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 12/2020. FULL PRESCRIBING INFORMATION: CONTENTS * 1 INDICATIONS AND USAGE. 1.1 Adjuvant Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) 1.2 First-line Treatment of EGFR Mutation-Positive Metastatic NSCLC
ORENCIA Patient Information - BMS
packageinserts.bms.comGeneral information about the safe and effective use of ORENCIA. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ORENCIA for a condition for which it was not prescribed. Do not give ORENCIA to other people, even if they have the same symptoms that you have. It may harm them.
Information, Patients, Patient information, Raciones, Orencia patient information
HIGHLIGHTS OF PRESCRIBING INFORMATION …
media.allergan.comSee 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 03/2021 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 Dosage Modifications 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 6 ADVERSE …
NUCALA (mepolizumab) for injection NUCALA (mepolizumab ...
gskpro.com17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. _____ 2 . FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . 1.1 Maintenance Treatment of Severe Asthma . NUCALA is indicated for the add-on maintenance treatment of adult and pediatric patients aged ...
ADAKVEO. ADAKVEO HIGHLIGHTS OF PRESCRIBING …
www.novartis.usPregnancy: May cause fetal harm. (See 17 for PATIENT COUNSELING INFORMATION and FDA-8.1) approved patient labeling. Revised: 7/2021 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 Preparation and Administration 2.3 Management of Infusion …
FDA-Approved Patient Labeling NEXPLANON (etonogestrel ...
www.organon.com1 FDA-Approved Patient Labeling NEXPLANON (etonogestrel implant) Radiopaque Subdermal Use Only NEXPLANON does not protect against HIV infection (the virus that causes AIDS) or other sexually transmitted diseases. Read this Patient Information leaflet carefully before you decide if NEXPLANON is right for you.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.com[see Patient Counseling Information (17)]. Do not take more than one dose in 24 hours. For administration of SPIRIVA HANDIHALER, a SPIRIVA capsule is placed into the center chamber of the HANDIHALER device. The SPIRIVA capsule is pierced by pressing and releasing the green piercing button on the side of the HANDIHALER device.
Patient Information and Consent - Doctors Care
doctorscare.comPatient Information and Consent. Patient Demographics Emergency Contact Information. Patient Employment Information Responsible Party's Information (if someone other than patient) Legal First Name Legal Last Name. Suffix Preferred First Name. What is the reason for your visit today? Have there been any changes to your information in the past 6 ...
PATIENT INFORMATION - epipen.com
www.epipen.comThis Patient Information Leaflet summarizes the most important information about the EpiPen and EpiPen Jr Auto-Injectors. If you would like more information, talk to your healthcare provider. You can ask your pharmacist or healthcare provider for information about the EpiPen and EpiPen Jr Auto-Injector that is written for health professionals.